Reply to the Letter to the Editor in response to "Role of autoantibody levels as biomarkers in the management of patients with myasthenia gravis: A systematic review and expert appraisal"

Affiliations

• ¹ Department of Neurology, Integrated Myasthenia Gravis Center, NeuroCure Clinical Research Center, Charité-Universitätsmedizin Berlin, Berlin, Germany.
• ² Neuroimmunology and Neuromuscular Diseases Unit, Scientific Institute for Research and Health Care Foundation Carlo Besta Neurological Institute, Milan, Italy.
• ³ Department of Neuromyology, Pitié-Salpêtrière Hospital, Public Hospital Network of Paris, Institute of Myology, Paris, France.
• ⁴ Scientific Institute for Research and Health Care, Catholic University of the Sacred Heart and Agostino Gemelli University Polyclinic Foundation, Rome, Italy.
• ⁵ Department of Neurology, Medical University of Warsaw, Warsaw, Poland.
• ⁶ Neurology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
• ⁷ Department of Medical Science, Clinical Neurophysiology, Uppsala University, Uppsala, Sweden.
• ⁸ Nice University Hospital Center, Nice, France.
• ⁹ Department of Neurology, University Hospital Cologne, Cologne, Germany.
• ¹⁰ Neurology, Leiden University Medical Center, Leiden, the Netherlands.
• ¹¹ Prescript Communications, Letchworth, UK.
• ¹² Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK.